Hansoh BioMedical R&D Company
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Hansoh BioMedical R&D Company
RECRUITINGPhase 3NCT06498479
ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer
The main objective of this study is to compare the efficacy of HS-20093 with standard of care (SOC) on prolonging overall survival (OS) in subjects with relapsed small cell lung...
Sponsor: Hansoh BioMedical R&D CompanyEnrolling: 4609 locations
Small Cell Lung Cancer
RECRUITINGPhase 2NCT06001255
ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors
HS-20093 is a fully humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. The objectives of this study...
Sponsor: Hansoh BioMedical R&D CompanyEnrolling: 12015 locations
Metastasis Castration Resistant Prostate Cancer(mCRPC)
RECRUITINGPhase 2NCT06176508
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of active psoriatic arthritis. Additionally, this study is to find the...
Sponsor: Hansoh BioMedical R&D CompanyEnrolling: 1601 location
Psoriatic Arthritis